This editorial highlights the feasibility and diagnostic yield of various AF screening programs in Hong Kong while emphasizing the critical need for structured downstream management to ensure appropriate anticoagulation.
Atrial fibrillation (AF) is the most common sustained heart rhythm disorder1 and has become a global epidemic especially in the developed countries with aging population. Although the risk of AF-related stroke can be markedly reduced by 64-70% by oral anticoagulation therapy,2 a major challenge remains to be the evasive nature of the condition to be diagnosed early for effective treatment. Around a quarter of patients have silent or asymptomatic AF3 and up to 25% of patients with AF-related stroke have AF diagnosed only at the time of stroke.
No takes yet. Share an insight, caveat, or question.
Ngai‐Yin Chan (2017) conducted an editorial in Atrial Fibrillation. Atrial fibrillation screening was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: